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Cultured Schwann Cells Constitutively Express
the Myelin Protein P0
Lili Cheng and Anne W. Mudge was used in the presence or absence of mitogens, P0
was induced only in cells that were not dividing (MorganMRC Developmental Neurobiology Programme
MRC Laboratory for Molecular Cell Biology et al., 1991, 1994), suggesting that withdrawal from the
cell division cycle is necessary for cAMP to signalDepartment of Biology
University College London Schwann cells to differentiate into a myelinating pheno-
type (Jessen and Mirsky, 1991; Jessen et al., 1991).Gower Street
London, WC1E 6BT Additional support for the idea that axons are needed
for Schwann cells to synthesize P0 came from the findingUnited Kingdom
of a 40-fold decrease in P0 mRNA in transected com-
pared with normal developing sciatic nerve (Trapp et
al., 1988). In contrast, however, LeBlanc and PodusloSummary
(1990) reported that the fall in P0 mRNA levels was only
5-fold if the comparison was made to a normal adult ratIt is widely thought that mammalian Schwann cells do
nerve rather than to an actively myelinating nerve fromnot express P0, the major glycoprotein in peripheral
immature rats. In addition, P0 protein continued to bemyelin, unless they are induced to do so by axonal
detectable in immunoblots of extracts of transectedsignals that can be mimicked by agents that trigger
nerves, and it was in a high mannose form, indicatingcAMP signaling pathways. In contrast, we find that
that it was retained in the endoplasmic reticulum (ER)culturedSchwann cells make largeamounts of P0 with-
and did not reach the Golgi apparatus or plasma mem-out the addition of any axonal-like signal, provided
brane (Poduslo, 1985; Poduslo et al., 1985).they have not been exposed to serum during the cul-
In the present study, we show that Schwann cellsture process. We also report that glial growth factor/
purified from newborn rat sciatic nerves constitutivelyneuregulin inhibits this constitutive P0 expression. My-
make large amounts of P0 when cultured in the absenceelin basic protein is regulated in a similar way. We
of axonal signals or agents that elevate cAMP. The ma-suggest that expression of P0 by Schwann cells before
jority of the protein is in the ER, although some is in thethe onset of myelination may be prevented by inhibi-
plasma membrane. Treatment with serum abolishes P0tory signals within the nerve, rather than by the ab-
expression, and this inhibitory effect persists for severalsence of a positive signal from axons.
days after serum is removed. Serum treatment also re-
duces the ability of the Schwann cells to survive whenIntroduction
transferred to serum-free medium, and this could ex-
plain the persistence of the serum effect. We also showMyelin protein zero (P0), the major protein component that, while Schwann cells proliferating in response toof peripheral myelin, is not normally expressed by mam-
mitogens can express P0, the expression is inhibited bymalian Schwann cells until myelination begins (Brockes
high concentrations of GGF. Myelin basic protein (MBP)et al., 1980; Trapp et al., 1981; Baron et al., 1994). It is
behaves in a similar fashion to P0.generally believed that Schwann cells require continual
These findings suggest that the reason mammalianpositive signaling from axons in order to synthesize P0
Schwann cells do not express P0 in vivo until myelination(Jessen and Mirsky, 1991; Fernandez et al., 1993;
begins is not because of the absence of a positive signalScherer et al., 1994). This belief originally came from the
from axons, but rather because P0 expression is inhib-observation that Schwann cells stop expressing P0 and
ited: GGF can apparently mimic this inhibition in culture.the myelin glycolipid galactocerebroside (GC) when
grown in culture in the absence of neurons, unlike oligo-
dendrocytes, which do express myelin components in Results
neuron-free cultures (Brockes et al., 1980; Mirsky et al.,
1980). Because agents such as forskolin that elevate Schwann Cells Do Not Require an Axonal
Signal to Synthesize P0intracellular cAMP levels can induce the expression of
both GC and P0 in neuron-free Schwann cell cultures Schwann cells were purified by negative immunopan-
ning from postnatal day 1 (P1) rat sciatic nerves, a time(Sobue and Pleasure, 1984; Lemke and Chao, 1988; Mo-
nuki et al., 1989; Morgan et al., 1991, 1994; Mews and when very few cells have begun to myelinate axons.
When cultured for 1 day in serum-free medium (BSM)Meyer, 1993), it has been suggested that cAMP may
mediate part of the axon-to-Schwann cell signaling pro- and stained by immunofluorescence with rabbit anti-P0
antibodies, the cells were intensely positive for P0 (P01)cess that is thought to trigger myelination in vivo (Jessen
and Mirsky, 1991; Jessen et al., 1991). (Figure 1A). After 7 days in culture, the cells had greatly
increased their surface area and were all still P01 (FigureAgents that elevate cAMP also synergize with mito-
gens such as platelet-derived growth factor (PDGF), ba- 1B); the cells stained in a striking reticular pattern indi-
cating that the majority of the P0 was located in the ER.sic fibroblast growth factor (bFGF), and glial growth fac-
tor (GGF) to promote Schwann cell proliferation in Schwann cells purified from P7 nerves contained cells
that had begun to myelinate and those that had not.culture (Davis and Stroobant, 1990; Weinmaster and
Lemke, 1990; Goodearl et al., 1993; Marchionni et al., After 1 day in culture, the 56% of cells that had begun
to myelinate before dissociation contained P01 myelin1993; Cheng et al., 1995). In experiments where forskolin
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Figure 1. Schwann Cells Immunolabeled with P0 Antiserum
In (A) and (B), Schwann cells were from P1 nerves; in (C) and (D), Schwann cells were from P7 rats. In (A), (B), and (C), cells were purified by
negative panning, and cells in (D) were purified by positive panning. Cells were cultured in serum-free medium for either 1 day (A, C, and D)
or 7 days (B). Cells were fixed with acid±alcohol, labeled with P0 antiserum (Brockes) followed by anti-rabbit biotin then streptavidin±fluorescein.
All experiments in this and the following figures were repeated at least 3 times with similar results. Scale bar 5 20 mm.
debris in their cytoplasm (Figure 1C, large arrow). Cells are P01 also express the myelin glycolipid galactocere-
broside (GC); note that the P0 in this micrograph hasthat did not contain P01 debris, however, were also P01
(Figure 1C, small arrow), and the P0 was mainly in the been visualized with indirect immunofluoresence and
the GC by the biotin±streptavidin amplification tech-ER. To eliminate the possibility that the axonal debris
in cultures of negatively panned cells was responsible nique, because the GC was difficult tosee without ampli-
fication; the P0 was visible with either method. P01 cellsfor inducing P0 expression [although such debris would
have been present in the studies by Brockes et al. (1980) were also positive for MBP, the low affinity nerve growth
factor receptor (LNGFR), as well as for the glycolipid O4and Mirsky et al. (1980)], we also purified both P1 and
P7 Schwann cells by positive selection on O4-antibody- (data not shown).
To study the intracellular distribution of the P0 in morecoated panning dishes. Although there was much less
debris in cultures of these cells, the cells were still in- detail, we examined the stained cells with a confocal
microscope. As shown in Figure 3A, the P0 was mainlytensely P01 after either 1 day in culture (Figure 1D) or
7 days in culture (data not shown). in an ER-like distribution, but there was some P0 in the
plasma membrane (arrows). The surface localization ofAs shown in Figures 2A and 2B, Schwann cells that
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Serum Inhibits the Constitutive Expression of P0
Because of the extensive literature documenting that
Schwann cells in culture require exogenous signals to
synthesize P0, we tried to determine the critical differ-
ences between our cultures and those of others. We
tested various factors including: growing the cells on
poly-D-lysine instead of laminin; passaging the cells
after 2 days in culture; growing cells at either high or
low density; pulsing the cells with cytosine arabinoside
for 2 days; adding a high density of sciatic nerve fibro-
blasts; and adding progesteroneand/or dexamethasone
to the culture medium. None of these suppressed the
expression of P0 by Schwann cells in serum-free
medium.
One factor had a dramatic effect, however. The addi-
tion of fetal calf serum (FCS) completely suppressed the
expression of P0. Schwann cells from P7 nerves purified
by negative panningwere all P01 after 7 days in culture in
serum-free medium (Figure 4A), whereas sister cultures
grown in 10% FCS were P02 after 1 day in culture (data
not shown) and 7 days in culture (Figure 4B). Moreover,
cells that were grown in FCS for 4 days and then washed
and grown in serum-free medium for a further 3 days
were only weakly positive for P0 (Figures 4C and 4D);
addition of 1 mM forskolin for the final 3 days in serum-
free medium restored the expression of P0 (Figure 4E).
The same results were obtained when the cells were
passaged at the time of serum withdrawal or when posi-
tively panned cells were used to avoid the addition of
Figure 2. Double Labeling of Schwann Cells with P0 and GC An- cytosine arabinoside (data not shown).
tibody When Schwann cells weregrown in FCS for 4 days and
Schwann cells negatively panned from P1 nerves were grown in then transferred to serum-free medium (with or without
culture for 7 days, fixed, and then immunolabeled. Indirect immuno- passaging), they were less viable than when they were
fluorescence with anti-rabbit fluorescein was used to label the P0 grown continuously in serum-free medium (compare the(A) and anti-mouse biotin followed by streptavidin±Texas red was
density of cells in Figures 4A, 4B, and 4E with that inused to label the GC (B). Scale bar 5 20 mm.
Figures 4C and 4D; the arrows point to dead Schwann
cells in Figure 4C). Cell viability was assessed using
P0 was more obvious in younger (<4 days) cultures than the MTT assay, which measures cell dehydrogenase
in 7 day cultures. Treatment of the cells for 6 hr with activity. As shown in Figure 5, cells were viable in either
cycloheximide (10 mM) to inhibit protein synthesis did serum-containing medium or serum-free medium for 9
not cause an appreciable redistribution of the P0 (data days. After removal of serum, however, the Schwann
not shown). We also compared the rough ER (RER) in cells died unless forskolin was added to the medium.
electron micrographs of cells that were grown in defined The persistence of the inhibitory effect of serum on P0
medium and were P01 with those that were grown in expression could therefore be explained by the cell
serum and were P02 (see below). The RER of cells grown death that occurred following serum removal. Moreover,
in serum-free medium (and therefore P01) is both swol- the effect of forskolin on P0 expression in cells transfered
len and more abundant than in the serum-treated (P02) to serum-free medium could be due to its cell survival±
cells (Figures 3B and 3C). promoting activity rather than to its P0-inducing activity;
The Brockes anti-P0 antiserum used in this study has the weak expression of P0 in the dying cells (Figures 4C
been well characterized by Western blotting (Brockes and 4D) supports this view.
et al., 1980) and has been used in many studies of myelin
development (Mirsky et al., 1980; Jessen et al., 1985;
Clemence et al., 1989; Morgan et al., 1991). The immu- GGF-2 and bFGF Inhibit P0 Expression at High
Concentrations, But Dividing Schwann Cellsnofluoresence labeling patterns in Figures 1B, 4A, and
4E are the same as those reported by Morgan et al. Can Express P0
We tried to identify factors that might inhibit Schwann(1991) in forskolin-treated cultures labeled with thesame
Brockes antiserum, although Morgan et al. did not com- cell expression of P0 within the nerve before the onset
of myelination. Growth factors, neurotrophins, and cyto-ment on the ER-like localization. We obtained the same
results with a second anti-P0 antiserum made by Morgan kines were tested for their ability to inhibit expression
of P0 in the presence or absence of forskolin by addinget al. (1994). We also performed a Western blot with the
Brockes antiserum (see Figure 7). For MBP immunoflu- them to the cells at the time of plating and looking at
P0 expression over the following 4 days, as well as byorescence and Western blotting, we used a well-charac-
terized antiserum prepared by Colman et al. (1982). adding them to cells after 4 days in culture when they
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Figure 3A. Confocal Microscope Image of
Schwann Cells Labeled with P0 Antiserum
and Electron Micrographs Showing Differ-
ences in Extent of Schwann Cell RER
(A) Cells were derived from P7 rats, immuno-
purified by positive panning, and cultured in
serum-free medium (BSM) for 7 days. The
typical ER-like P0 labeling pattern is out of
the plane of focus of the micrograph. The
arrows point to P0 labeling with the typical
edge effect characteristic of plasma mem-
brane labeling. By optical sectioning, thecells
were estimated to be less than 1 mm thick
except around the nucleus and processes.
Scale bar 5 5 mm.
(B and C) Electron micrographs showing
Schwann cell RER. Schwann cells from P7
rats were grown for 7 days in either serum-
free medium (B) or in 10% FCS (C) and pro-
cessed for electron microscopy. Arrows point
to RER; the asterisk in (B) indicates granular
material within the lumen of the expanded
RER. Scale bar 5 2.6 mm.
were already expressing P0 and examining them over or when added to 4-day cultures when the cells were
already expressing high levels of P0 (Table 2). The inhibi-the following 3 days.The following proteins had no effect
on P0 expression: PDGF-BB, interleukin-1, leukemia in- tion of P0 expression by high doses of GGF was compa-
rable to the inhibition seen with serum (Table 2).hibitory factor, oncostatin-M, ciliary neurotrophic factor,
as well as the neurotrophins, nerve growth factor, brain- To determine whether the inhibition of P0 by GGF-2
or bFGF was correlated with Schwann cell proliferation,derived growth factor, and neurotrophin-3. Trans-
forming growth factor-b inhibited P0 expression, but it we also measured DNA synthesis on each day after the
addition of GGF-2 or bFGF by adding bromodeoxyuri-also tended to kill the Schwann cells in serum-free cul-
tures, making interpretation of the inhibition difficult. In dine (BrdU) for 24 hr and then counting the number of
BrdU1 cells as a percentage of the total cells. We usedcontrast, the cells remained healthy in the presence of
either GGF-2 or bFGF, but P0 expression was inhibited sister cultures for BrdU and P0 labeling rather than dou-
ble labeling, because we found that a 24 hr pulse ofin a dose-dependent fashion; inhibition was seen when
the factors were added at the time of plating (Table 1) BrdU diminished the intensity of P0 labeling. We tested
Myelin Protein Expression by Schwann Cells
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Figure 4. Effect of FCS on P0 Expression
Schwann cells from P7 nerves were purified by negative panning and labeled with P0 antiserum after 7 days in culture. In (A), cells were
grown in serum-free medium (BSM) for 7 days; in (B), cells were grown in 10% FCS for 7 days; in (C), (D) and (E), cells were grown in 10%
FCS for 4 days and then switched to either serum-free medium (C and D) or serum-free medium with 1 mM forskolin (E) for another 3 days.
The arrows in (C) point to dead cells. All cells were treated with 1025M cytosine arabinoside on day 2 and then washed and re-fed with the
appropriate medium on day 4. Scale bar 5 20 mm. Similar results to those shown in (C) were seen in at least 12 different experiments where
cells were transferred from several types of serum-containing medium to serum-free medium.
doses of GGF-2 and bFGF that gave half-maximal stimu- by forskolin (see also Cheng and Mudge, unpublished
data).lation of division (25 pM and 62 pM, respectively), as
well as doses above those needed for maximal response As shown in Table 1, cells proliferating in response
to 25 pM GGF-2 or 62 pM bFGF for 4 days still expressed(250 pM and 625 pM, repectively). Whereas Schwann
cell proliferation in response to GGF was not affected P0, although at reduced levels compared with untreated
cells. Higher doses of GGF-2 and bFGF completely abol-by agents such as forskolin that stimulate cAMP accu-
mulation, proliferation in reponse tobFGF was increased ished P0 immunofluorescence. Although expression of
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24 hr on each day following addition of PDGF and for-
skolin; the percentage of cells incorporating BrdU on
each day was 55% 6 3%, 89% 6 1%, and 88% 6
1%, respectively. Note that the dividing cells were more
elongated and had less extensive P01 ER sheets (Figure
6) than the nondividing cells (Figures 1B and 4A), al-
though the intensity of the P0 labeling was similar in
dividing and nondividing cells.
Western blot analysis of P0 expression with the
Brockes antiserum of extracts of Schwann cells grown
in serum-free medium for 7 days revealed a band at 30
kDa, which corresponds to the major P0 band seen in
an extract of P7 rat sciatic nerve. This band was greatly
decreased when the Schwann cells were grown either
in 10% FCS or in serum-free medium containing 250
pM GGF-2 for the last 2 days of culture (Figure 7). MBP
behaved similarly: four bands characteristic of MBP
were expressed in serum-free cultures and were down-
regulated in FCS or GGF.
Discussion
In contrast to previous studies, we find that purified
Schwann cells from postnatal rat sciatic nerve make
large amounts of P0, as well as MBP and GC, when
cultured in theabsence of neurons or agents that elevate
Figure 5. Effect of FCS on Cell Survival
intracellular cAMP. This is the case even for Schwann
Schwann cells from P7 nerves were purified by negative panning
cells derived from P1 animals, a time when very few ofand cultured for 7 days. Cells were grown in similar conditions to
the cells have begun to myelinate or express P0 in vivo.those shown in Figure 4 and, on the days indicated, viability of
These results suggest that the reason why Schwanncells was assessed by the MTT assay. Cells were grown in defined
medium for 7 days (record ªAº); in 10% FCS for 7 days (record ªBº); cells in the developing postnatal rat nerve do not yet
in 10% FCS for 4 days and then switched to serum-free medium express P0 is that they are prevented from doing so by
for another 3 days (record ªCº); or in 10% FCS for 4 days and then inhibitory signals, and not because they cannot make
switched to serum-free medium with 1 mM forskolin for another 3
P0 until they are induced to do so by signals from axons,days (record ªDº). The symbols represent the mean 6 SD of 3 sam-
as is widely believed. One possibility is that axons pro-ples; 300 cells were counted in each sample.
vide the inhibitory signal, which is relieved when
Schwann cells start to wrap the axons. Another is that
when axons are ready to be myelinated, they provide aP0 in forskolin-treated cells was only marginally more
intense than in control cells, forskolin treatment over- positive signal that overrides an inhibitory signal from
another source.rode the inhibitory effect of low doses of either GGF or
bFGF and stimulated a low level of P0 expression in cells The electron micrographs show that the P01 cultured
Schwann cells have a greatly expanded RER, consistenttreated with high doses of either GGF or bFGF. The cells
generally behaved as a single population in that the with the prominent ER-like pattern revealed by the P0
immunolabeling. Otherwise the cells appear normal.growth factors decreased the intensity of staining in all
cells as opposed to changing the percentage of cells Such a prominent RER is not normally seen in Schwann
cells, but is seen in cells that are producing abnormallythat expressed P0; an exception was that a few cells
(<2%) expressed very high levels of P0 in the growth large amounts of RER proteins (Pathak et al., 1986) or
in cells secreting large amounts of protein, such as anti-factor-treated cultures. In cells that were dividing and
still P01, the extent of ER-like P0 staining was greatly body-producing cells. Although immunolabeling shows
that some P0 is in the plasma membrane, the majorityreduced and the cells had a more elongated morphology
(see also Figure 6A); at high doses of GGF-2 or bFGF, of the P0 is in the ER. The prominence of this labeling
pattern suggests that the Schwann cells in serum-freethe P02 cells were rounded with very short processes.
Similar results were seen when the growth factors were medium are, in effect, overexpressing P0. A possible
explanation for this is that cultured Schwann cells, hav-added after 4 days in culture (Table 2).
An example of dividing cells expressing P0 is shown ing lost the putative in vivo inhibitory signal, produce
an amount of P0 that would be appropriate for myelina-in Figures 6A and 6B. These cells were grown for 4 days
in serum-free medium and treated for a further 3 days tion but not appropriate for their nonmyelinating status
in culture. It is also possible that some componentswith PDGF-BB and 1 mM forskolin; BrdU was added for
the last 3 hr of culture and the cells double labeled for necessary for P0 traffic through the Golgi apparatus are
limiting. It is interesting in this respect that the P0 madeP0 and BrdU. To demonstrate that these double-labeled
cells had been dividing rapidly during the3 days in PDGF by Schwann cells in permanently transected nerves also
accumulates in the ER (Poduslo et al., 1985) and mayand forskolin, we labeled sister cultures with BrdU for
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Table 1. Effect of Growth Factors and Forskolin on Schwann Cell Proliferation and P0 Expression
2forskolin 1forskolin
(%) BrdU1 P0 labeling (%) BrdU1 P0 labeling
Day 2
Control 12.5 6 2.5 111 14.7 6 3.6 1111
GGF-2 (25 pM) 48.4 6 1.5 11 49.2 1 1.1 1111
GGF-2 (250 pM) 79.0 6 1.1 1 81.3 6 1.5 111
bFGF (62 pM) 48.9 6 1.8 11 76.8 6 3.2 111
bFGF (625 pM) 67.2 6 2.8 1 83.5 6 2.6 11
Day 3
Control 7.8 6 0.7 111 13.2 6 1.0 1111
GGF-2 (25 pM) 45.7 6 1.1 11 59.4 6 1.7 111
GGF-2 (250 pM) 73.6 6 1.5 6 79.3 6 1.7 1
bFGF (62 pM) 38.8 6 1.2 1 75.4 6 7.3 11
bFGF (625 pM) 48.8 6 2.4 6 82.7 6 2.1 1
Day 4
Control 6.3 6 0.6 1111 8.1 6 0.7 11111
GGF-2 (25 pM) 31.3 6 2.2 111 35.5 6 2.0 1111
GGF-2 (250 pM) 58.2 6 2.0 2 72.0 6 1.8 1
bFGF (62 pM) 27.7 6 4.6 1 72.7 6 5.5 11
bFGF (625 pM) 32.1 6 4.7 2 81.6 61.4 1
Schwann cells from P7 rat nerves were purified by negative immunopanning and plated in serum-free medium with the addition of either
GGF-2 or bFGF in the presence or absence of 1 mM forskolin, as indicated. After 2, 3, or 4 days in culture, cells were fixed and labeled with
P0 antiserum. The intensity of the labeling was scored as negative (2), barely detectable (6), or bright on a scale of 11 to 51. Sister cultures
were incubated with BrdU for 24 hr on either the second, third, or fourth day in culture; cells were then double labeled with anti-Thyl monoclonal
antibody and BrdU antiserum. Cells that were Thy-12 and BrdU1 were counted as a percentage of the total cells.
then be degraded by lysosomes (Brunden and Poduslo, Schwann cellswith the O4 monoclonal antibody to elimi-
nate any axonal debris. Immunopanning makes pulsing1987). We could find no evidence that P0 in cultured
with mitotic inhibitors in the presence of serum to elimi-Schwann cells was degraded in the lysosome after
nate fibroblasts unnecessary. Second, we plated theblocking protein synthesis. We suggest that the accu-
cells in serum-free medium and only treated the cellsmulation in the RER reflects the large scale production of
with serum when needed for the experiment, whereasP0 without the traffic to an expanding plasma membrane
other studies routinely used serum in the cultures. Wethat would normally accompany myelination.
find that serum from several sources greatly inhibitsThere are two significant differences between our
both the synthesis of P0 and GC in freshly platedSchwann cell cultures (Cheng et al., 1995, and this pa-
Schwann cells and in Schwann cells that have beenper), and those of others (Brockes et al., 1980; Mirsky
making P0 for 4 days in culture; in the latter case, P0 iset al., 1980; Sobue and Pleasure, 1984; Lemke and Chao,
barely detectable after 1 day in serum. Likewise, the1988; Monuki et al., 1989; Morgan et al., 1991, 1994;
expression of MBP is abolished by the addition of serumMews and Meyer, 1993). First, we used immunopanning
to the 4-day cultures. In agreement with others, we findwith OX42 and anti-Thy1 monoclonal antibodies toelimi-
that forskolin can overcome the inhibition by serum, asnate macrophages and fibroblasts from our cultures
all cells grown in serum plus forskolin show weak P0and, in some experiments, we also positively selected
labeling. We therefore conclude that the widespread use
of serum in Schwann cell cultures has led to the idea
that axon signals that can be mimicked by agents that
Table 2. Effect of Serum and Growth Factors on P0 Expression
elevate cAMP are required for P0 expression in vitro.
P0 Labeling In the studies by Morgan and colleagues (Morgan et
al., 1991, 1994), fibroblasts were first eliminated fromDay 4 Additions Day 5 Day 6 Day 7
the cultures by using a mitotic inhibitor with serum-
Control 1111 1111 11111 containing medium; the Schwann cells were then trans-
FCS 6 2 2
ferred to serum-free medium for experiments. We findCalf serum 6 2
that cells do not survive well after such a transfer butHorse serum 6 2
that forskolin promotes their survival in this condition.GGF (25 pM) 1111 1111 111
GGF (250 pM) 6 2 2 We also find that cultured Schwann cells survive for
GGF (625 pM) 6 2 2 long periods in serum-free medium only if they aregrown
bFGF (625 pM) 111 1 2 at high density, and that conditioned medium from high
density cultures rescues cells in low density cultures,Schwann cells from P7 rats were purified by negative panning and
plated in serum-free medium. After 4 days in culture, either 10% implying that the Schwann cells secrete autocrine sur-
serum, GGF-2 or bFGF was added to the cultures; after a further 1, vival factors (Cheng and Mudge, unpublished data). Be-
2, or 3 days in culture, cells were fixed and labeled with P0 antibody. cause such conditioned medium can rescue cells after
The intensity of the labeling was scored as negative (2), barely transfer from serum to serum-free medium, it is possible
detectable (6), or bright on a scale of 11 to 51.
that serum treatment inhibits expression of autocrine
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Figure 7. Western Blot Analysis of Sciatic Nerve and Schwann Cell
Cultures
Purified Schwann cells (106 cells) from P7 nerves were grown in
serum-free medium for 5 days and then the medium was changed
to either serum-free medium (lane 1), 10% FCS medium (lane 2), or
serum-free medium with 250 pM GGF-2 (lane 3), and the cultures
grown for a further 2 days. The cells were trypsinized off the dishes,
the cells counted, and proteins extracted. The lanes were loaded
with culture extracts normalized for viable cell numbers. An extract
from P7 sciatic nerves was also loaded (lane ªsnº); the amount was
adjusted to roughly match lane 1. Duplicate blots were labeled with
either anti-P0 (Brockes antiserum) or anti-MBP (Colman antiserum).
We find that P01 Schwann cells in serum-free medium
express a mixture of myelinating and nonmyelinating
phenotypic markersÐin that they express abundant
MBP, LNGFR, and the O4 antigen, as well as low levels
of GC. This suggests that there may not be a simple
switch between a nonmyelinating and a myelinating
phenotype, which is regulated by axonal signals and
can be mimicked by forskolin, as suggested by Jessen
and Mirsky (1992). Evidence that the control of the
change to a myelinating phenotype is likely to be more
complex comes from studies of a P0 knockout mouse
(Giese et al., 1992). In these mice, axons initiate the
process of myelination by signaling the Schwann cells
to wrap around the axons, but the expression of LNGFR
is not down-regulated as is normally the case, and sev-
eral other antigens are abnormally expressed.
In recent studies on the induction of P0 in Schwann
cells by neurons using cocultures with serum-free me-
dium (Bolin and Shooter, 1993; Fernandez et al., 1993),
the Schwann cells were prepared by first growing them
in serum, with or without expansion with mitogens andFigure 6. Expression of P0 in Proliferating Cells
forskolin, before switching to serum-free medium withPurified Schwann cells from P7 nerves were grown in serum-free
neurons. In these experiments, the neurons could bemedium for 7 days. PDGF-BB (10 ng/ml) and forskolin (1 mM) were
added on day 4. BrdU (1025M) was added 3 hr before the end of supplying survival signals for the Schwann cells, thereby
the experiment on day 7. The cells were then double labeled with confounding the interpretation of the results. Fernan-
P0 (A) and anti-BrdU (B) antibodies. In (A), the arrows point to BrdU- dez-Valle et al. (1993), however, did see P0 mRNA ex-labeled cells. Sister cultures to these cells, also in PDGF-BB and
pression in the majority of Schwann cells coculturedforskolin, were treated with BrdU for 24 hr periods to assess division
with neurons in serum-free medium and also found thaton each of the 3 days of treatment (see Results). Scale bar 5
P0 expression was inhibited in the presence of serum in20 mm.
agreement with our results. The focus of their study,
however, was the effect of basal lamina formation on the
process of myelination, and they did not report whetherSchwann cell survival signals and that forskolin restores
this expression. The survival-promoting effect of for- Schwann cells in serum-free medium without neurons
survived or expressed P0. In the study by Morrison etskolin could explain the conclusion by Morgan et al.
(1991) that forskolin, or agents that mimic axonal signals al. (1991), Schwann cells grown alone in serum-free me-
dium did not express P0 mRNA, but the cells assayed(Jessen et al., 1991), are required for Schwann cells to
express P0 in serum-free culture. were grown for 7 days without laminin at relatively low
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density, conditions where we find that Schwann cell require cAMP elevation in order to express P0 or prolifer-
ate in response to GGF (this paper and Cheng andsurvival is poor (Cheng and Mudge, unpublished data);
thus, their finding that axons induce P0 expression in Mudge, unpublished data) argue against this hypothe-
sis. Moreover, our finding that forskolin can overcomethese conditions needs to be interpreted with caution.
To explore what components in the nerve might inhibit several inhibitory effects of serum on Schwann cellsÐ
namely, P0 expression, the ability to survive in serum-P0 expression before myelination, we tested a number
of growth factors, neurotrophins, and cytokines to see free medium, and the ability to respond to mitogensÐ
adequately explains the differences in our conclusions.whether they inhibited the constitutive expression of P0
by Schwann cells in culture and found that, of those The finding that Schwann cells express P0 and MBP
constitutively and that this expression is inhibited bytested, only GGF-2 and bFGF did so. GGF-2 also abol-
ished the expression of MBP. We found that GGF inhib- the axonally derived mitogen GGF also has implications
for those studies carried out in culture to identify signalsited the expression of P0 at doses above those required
to stimulate cell proliferation. Although bFGF also inhib- that induce Schwann cells to myelinate axons: expres-
sion of P0 has often been used as a marker of myelinationited P0 expression, the availability of this growth factor
within the developing nerve is unclear because it is a in such studies, but these results should be interpreted
cautiously if P0 is expressed constitutively in the ab-cytoplamic protein.The inhibitory effect of GGF is partic-
ularly interesting because it is made by both motor and sence of axons.
sensory neurons during development (Marchionni et al.,
Experimental Procedures1993; Mudge, 1993) and because it is thought to function
as either a soluble or axonal membrane-bound Schwann
Materialscell mitogen (Marchionni et al., 1993; Morrissey et al.,
Reagents and tissue culture ware were obtained from suppliers as
1995). GGF is encoded by the neuregulin gene (Marchi- indicated in Cheng et al. (1995). The source of antibodies was as
onni et al., 1993), and there are many alternatively follows: rabbit anti-P0 was from Jeremy Brockes, but results were
spliced forms, including the proteins known as neu also compared with anti-P0 from Louise Morgan; rabbit anti-MBP
was from David Colman. The mouse anti-GC monoclonals (R28,O1)differentiation factor (NDF), acetylcholine receptor±
were from B. Ranscht and I. Somner, respectively; the anti-GC sul-inducing activity (ARIA), and heregulin (Mudge, 1993).
fatide (O4) was also from I. Somner; and the mouse anti-LNGFRThe detailed distribution of the various proteins, collec-
monoclonal (192) was from E. Johnson. The detection antibodies
tively known as neuregulins, within the peripheral nerve were all from Amersham, UK, except the anti-rabbit-fluorescein,
is not yet known. A change in availability of neuregulins which was from Wellcome Diagnosticum, UK.
or of their receptors (erbB2, erbB3, and erbB4) (Carra-
way and Burden, 1995) could play a part in releasing an Growth Factors
Recombinant growth factors were obtained from the followinginhibition of Schwann cell P0 expression at the onset of
sources: GGF-2 (80,000 kDa) was a gift from Cambridge Neurosci-myelination.
ence, MA, USA; PDGF-BB and interleukin-1b were purchased fromMorgan et al. (1991, 1994) have also reported that
R&D Systems, Inc., USA; nerve growth factor, brain-derived growth
bFGF, TGF-b, or crude preparations of GGF can inhibit factor, neurotrophin-3, ciliary neurotrophic factor, leukemia inhibi-
expression of P0 but, as discussed above, the interpreta- tory factor, bFGF, and oncostatin-M were purchased from Pepro-
tion of their results is complicated by their use of for- Tech, Inc., London, UK. Transforming growth factor-b1 was pur-
chased from Genzyme Diagnostics, MA, USA.skolin-stimulation of serum-treated Schwann cells. An
interesting difference between our results and theirs is
Preparation of Pure Schwann Cell Culturesthat we find that the Schwann cells respond homoge-
Negative Panningneously to serum, GGF, and bFGF: all inhibit P0 expres- Sciatic nerves were dissected from P1 or P7 rats, enzymatically
sion in all of the cells in a dose-dependent way, whereas dissociated to single cells, filtered through 20 mm gauze, and the
Morgan et al. (1991, 1994) report that the number of Schwann cells purified by immunopanning to remove OX42-positive
(OX421) blood cells and Thy-11 fibroblasts as previously describedforskolin-stimulated cells expressing P0 as a percent of
(Cheng et al., 1995). The cells obtained at this point were 98% S1001total cells decreases in response to each of these
Schwann cells and the contaminating cells were Thy-11 fibroblasts;agents.Moreover, there is less inhibition by these agents
there were no OX421 blood cells. These cells were plated at ain the presence of forskolin in our experiments. We also
density of 30,000 cells in a 50 ml drop on poly-D-lysine- and laminin-
find, in contrast to Morgan et al. (1991, 1994), that divid- coated glass cover-slips and then grown in serum-free, defined
ing Schwann cells can express P0, particularly when medium; the cells were routinely washed after 1 day. After 3 days
stimulated with forskolin, suggesting that the inhibition in culture, the contaminating fibroblasts were all pyknotic, and the
viable cells were >99.9% S1001 Schwann cells.by GGF or bFGF is not due simply to their ability to
Positive Panningpromote cell division, and could instead be due to a
In some cases, the cell suspension obtained after depletion ofmore direct inhibition of P0 gene expression. An example OX421 and Thy-11 cells was then incubated with immunopanning
of neuregulin affecting gene transcription without an dishes coated with O4 hybridoma supernate. After extensive wash-
effect on proliferation is the increase in expression of ing, the firmly adherent cells were removed from the dish with 0.05%
acetylcholine receptor genes in postmitotic muscle cells trypsin. These cells were then plated for experiments in defined
medium at a density of 30,000 cells/50 ml drop on poly-D-lysine-in culture (Chu et al., 1995; Jo et al., 1995).
and laminin-coated coverslips.Jessen and colleagues have proposed that cAMP sig-
Viability and Yield of Schwann Cellsnaling plays a pivotal role in switching Schwann cells
Following dissociation, the cell suspensions contained 95% viable
from a proliferating phenotype in the presence of mito- cells and, after negative panning, about 80% of the cells plated
gens to a myelinating phenotype in the absence of mito- were viable (see Figure 3). The yield of cells positively panned on
gens (Jessen and Mirsky, 1991, 1992; Jessen et al., O4 dishes was about 20% of the suspension applied, although most
of these cells were O41.1991). Our findings that cultured Schwann cells do not
Neuron
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Passaging Immunoblotting
We plated 106 Schwann cells onto 35 mm tissue culture dishesIn some cases, cellswere plated onto PDL and laminin-coated tissue
culture dishes, trypsinized off the dishafter 2 days and then replated coated with poly-D-lysine and laminin and cultured in serum-free
medium. After 4 days in culture, the medium was changed to serum-onto coverslips.
Growth Medium free medium with or without 250 pM GGF-2, or medium with 10%
FCS, and cells were grown for a further 2 days. Cultures wereSchwann cells were routinely grown in a 5% CO2 incubator at 378C
in Dulbecco's modified Eagle's medium (DMEM) with Glutamax-1 washed, and then cells were trypsinized off the dishes and an aliquot
counted for total cell number. Proteins were extracted from the cellsand Ham's F12 mixed 1:1 and supplemented with 100 U/ml Penicil-
lan and 100 mg/ml Streptomycin (DMEM/F12) containing defined with 0.1 ml of 125 mM Tris-HCL, 15% sucrose, 4% SDS, 10 mM
EDTA, and 100 mM DTT; proteins from P7 rat sciatic nerve wereadditives according to the suggestions of Bottenstein and Sato
(1979). The additives were as follows: 100 mg/ml transferrin, 16 mg/ extracted with the same buffer. The samples were boiled for 5 min,
spun at 14,000 g for 5 min, and then chomatographed using SDS-ml putrescine, 5 mg/ml insulin, 50 ng/ml thyroxine, 50 ng/ml tri-
iodothyronine, 39 ng/ml sodium selenite, 100 mg/ml crystalized polyacrylamide gel electrophoresis (12% gel). Culture samples
loaded onto the gel were adjusted for total cell number rather thanBSA; in some cases, 60 mg/ml progesterone and 38 mg/ml dexa-
methasone were also added. After 24 hr, the cells were washed 3 for protein because the serum would contibute significantly to the
total protein; the volume loaded corresponded to 2 3 105 cells. Thetimes with DMEM/F12 to remove debris and then returned to serum-
free medium with defined additives (BSM). When indicated, cells amount of nerve extract loaded was adjusted to be in approximately
the same detection range as the culture sample. After protein trans-were sometimes grown in 10% FCS, 10% calf serum, or 10% horse
serum. fer to nitrocellulose membranes, the blots were incubated for 1 hr
in PBS/0.1% Tween-20 with 5% milk powder followed by incubation
with primary antibody in the same solution for 2 hr. Blots were thenImmunolabeling
washed and incubated with horseradish peroxidase±conjugatedP0 Immunofluorescence
anti-Ig for 30 min. After washing, the blots were developed for 1Cells were fixed for 10 min in cold acid±alcohol (5% acetic acid
min with ECL detection reagents (Amersham Life Science, UK) andin ethanol), washed, then incubated overnight at 48C with anti-P0
exposed using XAR-5 photographic film (Kodak, NY).(Brockes et al., 1980), diluted 1/600 in PBS containing 4% FCS,
0.1% Triton X-100, and 0.1% sodium azide; after washing, the cells
Acknowledgmentswere incubated for 30 min at room temperature with biotinylated
donkey anti-rabbit Ig followed by streptavidin-fluorescein or with
We thank Cambridge Neuroscience, Inc., for the gift of human, re-anti-rabbit Ig conjugated to fluorescein. A second rabbit anti-P0
combinant GGF-2, and we thank the following for gifts of antibodies:obtained from L. Morgan (Morgan et al., 1994) was also used in
Jeremy Brockes, Louise Morgan, David Colman, Barbara Ranscht,order to compare the staining patterns. Specificity of P0 immunofluo-
Ilse Sommer. We are also grateful to Dr. Mark Shipman (MRC-LMCB)rescence was checked also by Western blotting.
for help with the confocal microscope and to Dr. Lindsay HewletMBP Immunofluorescence
(MRC-LMCB) for providing the electron micrographs. Paul PreeceCells were fixed with cold methanol and stained with anti-MBP
helped with the photography and Martin Raff provided his usual(Colman et al., 1982) as for anti-P0.
helpful comments on the paperÐthanks. We also thank our col-Cell Surface Antigen Immunofluoresence
leagues in the LMCB for many useful discussions.Live cells were incubated for 30 min at room temperature with hy-
The costs of publication of this article were defrayed in part bybridoma supernates R-28 (Ranscht et al., 1982), O1 and O4 (Sommer
the payment of page charges. This article must therefore be herebyand Schachner, 1981), or 192 (Taniuchi and Johnson, 1985) diluted
marked ªadvertisementº in accordance with 18 USC Section 17341:1 with L15 medium containing 4% FCS and 0.1% sodium azide.
solely to indicate this fact.After washing, the cells were incubated with biotinylated sheep anti-
mouse Ig for 30 min at room temperature followed by streptavidin±
Received September 26, 1995; revised November 3, 1995.Texas red or with anti-mouse Ig conjugated to Texas red; labeled
cells were then fixed with cold acid alcohol for 10 min and then
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